Industries > Pharma > The Point of Care Diagnostics Market Forecast 2014-2024

The Point of Care Diagnostics Market Forecast 2014-2024

Future Prospects for Leading Companies

PUBLISHED: 09 April 2014
PAGES: 308
PRODUCT CODE:
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
SKU: N/A Categories: ,

Point of care diagnostics – discover technological and commercial prospects
What does the future hold for the point of care diagnostics market? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.

Our 308 page report provides 173 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market, submarket and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions.

Forecasts from 2014-2024 and other analyses show you commercial prospects
Besides revenue forecasting to 2024, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT, Porter’s Five Forces and PESTEL), company profiles and commercial developments. Read the full transcripts of four exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales:
• Dr. Terenzio Facchinetti, Director Business Development, UL International GmbH
• Dr. Keith Batchelder, CEO and Founder of Genomic Healthcare Strategies (GHS), USA
• Dr. David Huckle, President and CEO of Adams Business Associates (ABA), UK
• Dr. Stephan Cohen-Bacrie, Co-director of the Multi-site Laboratory of Immunohematology and Immunogenetics, French Blood Establishment

You will find prospects for key submarkets
In addition to analyses of the overall world market, you will see revenue forecasting of seven world-level submarkets to 2024:
• Blood glucose testing market
• Coagulation testing market
• Cardiac marker testing market
• Infectious diseases testing market
• Pregnancy testing market
• Cholesterol testing market
• Other point of care diagnostics markets

In general, each submarket is further segmented by components and discussions for leading regional markets within each submarket are also provided.

Our investigation shows business research and analysis with individual revenue forecasts and discussions. How will the point of care diagnostic markets expand? This study will allow you to thoroughly understand the industry, finding the most promising places for investments and sales.

What are the prospects in the leading regions and countries?
Events and progress worldwide will influence the market. In our study you will find individual revenue forecasts to 2024 for 15 national markets:
• US
• Japan
• Germany
• UK
• France
• Italy
• Spain
• Netherlands
• Belgium
• Switzerland
• Brazil
• Russia
• India
• China
• South Korea
• RoW

Many opportunities exist within the point of care diagnostics market. Greater uptake of existing technology and products worldwide will also stimulate the industry and market. With our new investigation you will gain business research and analysis with individual sales predictions and discussions. You will find analysis of competition, as well as commercial drivers and restraints. See what is likely to achieve the most success.

Additionally, you will find individual revenue forecasts to 2024 for 15 leading IVD national markets:
• US
• Germany
• France
• Italy
• Spain
• UK
• Netherlands
• Belgium
• Switzerland
• Japan
• China
• India
• South Korea
• Brazil
• Russia
• Row

Leading companies and potential for market growth
Overall world revenue for the point of care diagnostics market will reach $17.2bn in 2014, our work forecasts. We predict strong revenue growth from 2014 to 2024. Our work shows you what organisations hold greatest potential. See profiles of four leading companies, including these:
• Roche
• Abbott
• Siemens
• Alere

In general, a company profile gives you the following information:
• Overview of the company, including its history in the market
• Revenue forecasts from 2014 to 2024
• Discussion of a company’s activities and outlook including descriptions of leading products
• Recent financial results
• Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborations, inc. alliances, partnerships and joint ventures

What issues will affect the point of care market?
Our new report discusses issues and events affecting the point of care market. You will find discussions, including qualitative analyses:
• An ever-growing patient population with chronic diseases
• An aging population
• Globalisation of infectious diseases and associated public health concerns
• Increasing demand for better monitoring and control of diseases
• Telehealth and remote communications between diagnostics and laboratories
• Global focus on personalised medicine

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How The Point of Care Diagnostics Market Forecast 2014-2024: Future Prospects for Leading Companies report helps you
In summary, our 307 page report gives you the following knowledge:
• Revenue forecasts to 2024 for the overall world point of care diagnostics market and 7 submarkets – discover the industry’s prospects, finding promising places for investments and revenues
• Assessment of leading companies, and others, discovering activities and outlooks
• Market forecasting to 2024 for 15 leading regions and countries in the POC diagnostics market and IVD market – USA, Japan, Germany, France, UK, Spain, Italy, Netherlands, Belgium, Switzerland, Brazil, Russia, China, India, South Korea and RoW.
• View opinions from our survey, seeing 4 interviews with leading authorities
• Investigation of competition and opportunities influencing sales
• Discussion of what stimulates and restrains the point of care diagnostics market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See there how you could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the point of care diagnostics market. You find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

To see sample pages of this report click here

Download sample pages

Complete the form below to download your free sample pages for The Point of Care Diagnostics Market Forecast 2014-2024


Download sample pages

Complete the form below to download your free sample pages for The Point of Care Diagnostics Market Forecast 2014-2024


Latest Pharma news

Visiongain Publishes Dermatological Drugs Market Report 2021-2031

The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.

18 January 2021

READ

Visiongain Publishes Antigen Skin Test Market Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.

12 January 2021

READ

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.

11 January 2021

READ

Visiongain Publishes Anti-Infective Vaccines Market Report Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.

11 January 2021

READ

Categories

Category